How to do without steroids in inflammatory bowel disease

Dearing, 1950, Experiences with cortisone and ACTH in chronic ulcerative colitis, Mayo Clin Proc, 25, 486

Kirsner, 1959, Corticotrophin and the adrenal steroids in the management of ulcerative colitis, Ann Intern Med, 50, 891, 10.7326/0003-4819-50-4-891

Korelitz, 1964, The influence of corticotrophin and adrenal steroids in the course of ulcerative colitis: a comparison with the pre-steroid area, Gastroenterology, 96, 671, 10.1016/S0016-5085(64)80024-X

Truelove, 1955, Cortisone in ulcerative colitis: final report on a therapeutic trial, BMJ, 2, 1041, 10.1136/bmj.2.4947.1041

Truelove, 1959, Cortisone and corticotrophin in ulcerative colitis, BMJ, 1, 387, 10.1136/bmj.1.5119.387

Lennard-Jones, 1965, Prednisone as maintenance treatment for ulcerative colitis in remission, Lancet, 1, 188, 10.1016/S0140-6736(65)90973-6

Powell-Tuck, 1981, A controlled trial of alternate day prednisolone as a maintenance treatment for ulcerative colitis in remission, Digestion, 22, 263, 10.1159/000198667

Babb, 1988, Corticosteroids in ulcerative colitis. A sceptical view, J Clin Gatroenterol, 10, 365, 10.1097/00004836-198808000-00003

Baron, 1962, Outpatient treatment of ulcerative colitis. Comparison between three doses of oral prednisolone, BMJ, 2, 441, 10.1136/bmj.2.5302.441

Powell-Tuck, 1978, A comparison of oral prednisolone given as a single or multiple daily doses for active proctocolitis, Scand J Gastroenterol, 13, 833, 10.3109/00365527809182199

Kaplan, 1975, A controlled evaluation of intravenous adrenocorticotropic hormone and hydrocortisone in the treatment of acute colitis, Gastroenterology, 69, 91, 10.1016/S0016-5085(19)32640-X

Meyers, 1983, Corticotrophin versus hydrocortisone in the intravenous treatment of ulcerative colitis, Gastroenterology, 85, 351, 10.1016/0016-5085(83)90323-2

George, 1996, The long term outcome of ulcerative colitis treated with 6-mercaptopurine, Am J Gastroenterol, 91, 1711

Hawthorne, 1992, Randomized controlled trial of azathioprine withdrawal in ulcerative colitis, BMJ, 305, 20, 10.1136/bmj.305.6844.20

Kozarek, 1989, Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease, Ann Intern Med, 110, 353, 10.7326/0003-4819-110-5-353

Sandborn, 1995, A critical review of cyclosporine therapy in inflammatory bowel disease, Inflammatroy Bowel Diseases, 1, 48, 10.1097/00054725-199503000-00006

Lichtiger, 1994, Cyclosporine in severe ulcerative colitis refractory to steroid therapy, N Egl J Med, 330, 1841, 10.1056/NEJM199406303302601

Marion, 1996, 6-MP maintains cyclosporine induced response in patients with severe ulcerative colitis, Am J Gastroenterol, 91, A1975

D'Haens, 1998, Intravenous cyclosporine monotherapy versus methylprednisolone therapy in severe ulcerative colitis: a randomized double blind placebo controlled trial, Gastroenterology, 114, A963

Jones, 1966, Corticosteroids and corticotrophin in the treatment of Crohn's disease, Gut, 7, 181, 10.1136/gut.7.2.181

Sparberg, 1966, Long term corticosteroid therapy for regional enteritis. An analysis of 58 courses in 54 patients, Am J Dig Dis, 11, 865, 10.1007/BF02233943

Cooke, 1970, Corticosteroid or corticotrophin therapy in Crohn's disease (regional enteritis), Gut, 11, 921, 10.1136/gut.11.11.921

Summers, 1979, National Cooperative Crohn's Disease Study. Results of drug treatmem, Gostroenterology, 77, 847, 10.1016/0016-5085(79)90385-8

Malchow, 1984, European Cooperative Crohn's Disease Study. Results of drug treatment, Gastroenterology, 86, 249, 10.1016/0016-5085(84)90409-8

Bergman, 1976, Postoperative treatment with corticosteroids and salazopyrin after radical resection of Crohn's disease, Scan J Gastroenterol, 2, 651, 10.1080/00365521.1976.12097167

Smith, 1978, Low dose steroids and clinical relapse in Crohn's disease in a controlled trial, Gut, 19, 606, 10.1136/gut.19.7.606

Brignola, 1988, The possible utility of steroids in the prevention of relapses of Crohn's disease in remission, J Clin Gastroenterol, 10, 631, 10.1097/00004836-198812000-00011

Modigliani, 1990, Clinical, biological and endoscopic pictures of attacks of Crohn's disease, Gastroenterology, 98, 811, 10.1016/0016-5085(90)90002-I

Shepherd, 1986, Use of intravenous steroid regimen in the treatment of acute Crohn's disease, J Clin Gastroenterol, 4, 154, 10.1097/00004836-198604000-00010

Munkholm, 1994, Frequency of glucocorticoid resistance and dependency in Crohn's disease, Gut, 35, 360, 10.1136/gut.35.3.360

Steinhart AH Ewe K Griffiths AM Review: corticosteroid therapy does not reduce the rate of relapse in Crohn's disease 1998

Ausonoki, 1992, Steroid complications in patients with ulcerative colitis, Dis Colon Rectum, 35, 1003, 10.1007/BF02253508

Spencer, 1962, Immediate and prolonged therapeutic effects of corticotrophin and adrenal steroids in ulcerative colitis, Gastroenterol, 42, 113, 10.1016/S0016-5085(62)80093-6

Wolkowitz, 1997, Glucocorticoid medication, memory loss and steroid psychosis in medical illness, Ann NY Acad Sci, 823, 81, 10.1111/j.1749-6632.1997.tb48381.x

Stuck, 1989, Risk of infectious complications in patients taking glucocorticoids, Rev Infect Dis, 11, 954, 10.1093/clinids/11.6.954

Valentine, 1999, Clinical review: Prevention and treatment of osteoporosis in patients with inflammatory bowel disease, Am J Gastroenterol, 94, 878, 10.1111/j.1572-0241.1999.981_d.x

Akerkar, 1997, Corticoste-roid-associated complications in elderly Crohn's disease patients, Am J Gastroenterol, 92, 461

Conn, 1994, Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy, J Int Med, 236, 619, 10.1111/j.1365-2796.1994.tb00855.x

McEvoy, 1997, Adverse effects of corticosteroid therapy for COPD, Chest, 111, 732, 10.1378/chest.111.3.732

Greenstein, 1986, Perforating and non-perforating indications for surgery in Crohn's disease. Evidence for two clinical forms, Gut, 29, 588, 10.1136/gut.29.5.588

Aberhardt, 1996, Surgical recurrence of perforating and nonperforating Crohn's disease, Dis Colon Rectum, 39, 80, 10.1007/BF02048274

Wheeler, 1998, Medical therapy, not surgery is the appropriate first-line treatment for Crohn's enterovesieal fistula, Gastroenterology, 114, A1113, 10.1016/S0016-5085(98)84526-5

Greenberg, 1994, Oral budesonide for active Crohn's disease, N Engl J Med, 331, 836, 10.1056/NEJM199409293311303

Rutgeerts, 1994, A comparison of budesonide with prednisolone for active Crohn's disease, N Engl J Med, 331, 842, 10.1056/NEJM199409293311304

Greenberg, 1996, Oral budesonide's maintenance treatment for Crohn's disease. A placebo-controlled dose ranging study, Gastroenterology, 110, 45, 10.1053/gast.1996.v110.pm8536887

Singleton, 1993, Mesalamine capsules for the treatment of active Crohn's disease. Results of a 16-week trial, Gastroenterology, 104, 1293, 10.1016/0016-5085(93)90337-C

Messori, 1994, Effectiveness of 5-aminosalicylic acid for maintaining remission in patients with Crohn's disease. A meta-analysis, Am J Gastroenterol, 89, 692

Steinhart, 1994, Sulfasalazine and mesalamine for maintenance therapy of Crohn's disease. A meta-analysis, Am J Gastroenterol, 89, 211

Prantera, 1999, Mesalamine in the treatment of mild to moderate active Crohn's ileitis: results of a randomized multi-center trial, Gastroenterology, 116, 521, 10.1016/S0016-5085(99)70172-1

Moss, 1978, Radiological and clinical assessment of broad spectrum antibiotic therapy in Crohn's disease, Am J Roentgen, 131, 787, 10.2214/ajr.131.5.787

Graham, 1995, Prolong remission in Crohn's disease following therapy for mycobacteria and tuberculosis infection, Gastroenterology, 108, A826, 10.1016/0016-5085(95)27612-2

Rubin, 1996, Clarithromycin in active Crohn's disease. Preliminary results from an open label pilot study, Gastroenterology, 110, A1005

Prantera, 1996, An antibiotic regimen for the treatment of active Crohn's disease. A randomized controlled clinical trial with metronidazole versus ciprofloxacin, Am J Gastroenterol, 91, 328

Colombel, 1999, A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease, Am J Gastroenterol, 94, 674, 10.1111/j.1572-0241.1999.935_q.x

Turunen, 1993, Long term outcome of ciprofloxacin treatment of severe perianal or fistulous Crohn's disease, Gastroenterology, 104, A793

Ursing, 1982, Comparative study of metronidazole and sulfasalazine for active Crohn's disease, Gastroenterology, 83, 550, 10.1016/S0016-5085(82)80189-3

Sutherland, 1991, Double blind placebo controlled trial of metronidazole in Crohn's disease, Gut, 32, 1071, 10.1136/gut.32.9.1071

Brandt, 1982, Metronidazole therapy for perineal Crohn's disease. A follow-up study, Gastroenterology, 83, 383, 10.1016/S0016-5085(82)80332-6

Peppercorn, 1993, Are antibiotics useful in the management of nontoxic severe ulcerative colitis?, J Clin Gastroenterol, 17, 14, 10.1097/00004836-199307000-00005

Dickinson, 1985, Double blind controlled trial of oral vancomycin as adjunctive therapy in acute exacerbations of ulcerative colitis, Gut, 26, 1380, 10.1136/gut.26.12.1380

Mantzaris, 1994, Intravenous tobramycin and metronidazole as an adjunct to corticosteroids in acute severe ulcerative colitis, Am J Gastroenterol, 89, 43

Turunen, 1998, Long-term treatment of ulcerative colitis with ciprofloxacin: a prospective double blind placebo controlled trial, Gastroenterology, 115, 1072, 10.1016/S0016-5085(98)70076-9

Present, 1998, Ciprofloxacin as a treatment for ulcerative colitis- not yet, Gastroenterology, 115, 1289, 10.1016/S0016-5085(98)70104-0

Present, 1989, 6-mercaptopurine and other immunosuppresive agents in the treatment of Crohn's disease and ulcerative colitis, Gastroenterol Clin NA, 18, 57, 10.1016/S0889-8553(21)00426-X

Pearson, 1995, Azathioprine and 6-mercaptopurine in Crohn's disease. A meta-analysis, Ann Intern Med, 122, 132, 10.7326/0003-4819-123-2-199507150-00009

Present, 1983, Treatment of Crohn's disease with 6-mercaptopurine in a long term, randomized, double blind study, N Engl J Med, 2, 981

Ewe, 1993, Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn's disease, Gastroenterology, 105, 367, 10.1016/0016-5085(93)90709-L

Markowitz, 1998, 6-mercaptopurine and prednisone therapy for newly diagnosed pediatric Crohn's disease. a prospective multicenter placebo controlled trial, Castroenterol, 114, A1032, 10.1016/S0016-5085(98)84200-5

O'Donoghue, 1978, Double blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease, Lancet, 2, 955, 10.1016/S0140-6736(78)92524-2

Korelitz, 1985, The favorable effects of 6-mercaptopu-rine in the fistula of Crohn's disease, Dig Dis Sci, 30, 58, 10.1007/BF01318372

Sandborn, 1995, An intravenous loading dose of azathioprine decreases the time to response in subjects with Crohn's disease, Gastroenterology, 109, 1808, 10.1016/0016-5085(95)90747-5

Sandborn, 1999, Lack of effective intravenous administration on time to respond to azathioprine for steroid treated Crohn's disease, Gastroenterology, 117, 527, 10.1016/S0016-5085(99)70445-2

Present, 1989, 6-mercaptopurine in the management of inflammatory bowel disease: short and long term toxicity, Ann Intern Med, 111, 641, 10.7326/0003-4819-111-8-641

Kirschner, 1998, Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease, Gastroenterology, 115, 813, 10.1016/S0016-5085(98)70251-3

Connell, 1994, Long term neoplasia risk after Azathioprine treatment in inflammatory bowel disease, Lancet, 343, 1249, 10.1016/S0140-6736(94)92150-4

Francella, 1996, 6-mercaptopurine is safe therapy for childbearing patients with inflammatory bowel disease: a case controlled study, Gastroenterology, 110, A909

Feagan, 1995, Methotrexate for the treatment of Crohn's disease, N Engl J Med, 332, 292, 10.1056/NEJM199502023320503

Lemann, 1996, Memotrexate for the treatment of refractory Crohn's disease, Aliment Pharmacol Ther, 10, 309, 10.1111/j.0953-0673.1996.00309.x

Muhadevan, 1997, The place for methotrexate in the treatment of refractory Crohn's disease, Gastroenterology, 112, A1031

Brynskov, 1989, Placebo controlled double blind randomized trial of cyclosporine therapy in active Crohn's disease, N Engl J Med, 321, 845, 10.1056/NEJM198909283211301

Feagan, 1994, Low dose cyclosporine for the treatment of Crohn's disease, N Engl J Med, 330, 1846, 10.1056/NEJM199406303302602

Stange, 1995, European trial of cyclosporine in chronic active Crohn's disease: a 12-month study, Gastroenterology, 109, 774, 10.1016/0016-5085(95)90384-4

Present, 1994, Efficacy of cyclosporine in treatment of fistula of Crohn's disease, Dig Dis Sci, 39, 374, 10.1007/BF02090211

Hanauer, 1993, Rapid closure of Crohn's disease fistula with continuous intravenous cyclosporine, A. Am J Gastroenterol, 88, 646

Egan, 1998, Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine, Am J Gastroenterol, 93, 442, 10.1111/j.1572-0241.1998.00442.x

Lemann, 1998, Intravenous cyclosporine for refractory attacks of Crohn's disease: long term follow-up of patients, Gastroenterology, 114, A1020, 10.1016/S0016-5085(98)84151-6

Sternthal, 1996, Toxicity associated with the use of cyclosporine in patients with inflammatory bowel disease, Gastroenterology, 110, A1019

Targan, 1997, A short term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease, N Engl J Med, 337, 1029, 10.1056/NEJM199710093371502

Present DH Personal communication. Celltech Chiroscience 1999 1999

Present, 1999, Infliximab for the treatment of fistulas in patients with Crohn's disease, N Engl J Med, 340, 1398, 10.1056/NEJM199905063401804